Sanofi grew sales and business EPS(1) in Q3 2015
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
Sanofi (SNY) Reports Q3 EPS of EUR1.25
October 29, 2015 6:18 AM EDTSanofi (NYSE: SNY) reported Q3 EPS of EUR1.25, versus EUR0.91 reported last year. Revenue for the quarter came in at EUR9.59 million, versus EUR8.78 million reported last year.
Broad-based sales growth despite Diabetes sales erosion in the U.S.
